2012 EIF REVLON Run/Walk For Women Team Captain's Manual

Join the Fight!Money Raised = Research Funds = Lives SavedIn the last eighteen years, the EIF REVLON Run/Walk For Women has distributed over 65 million dollarsfor women’s cancer research. The money raised has helped fund critical research that has led the wayfor groundbreaking new therapies. One example is the drug Herceptin which, according to Dr. DennisSlamon, Director of the REVLON/UCLA Women’s Cancer Research Program, when used at the time ofdiagnosis increases the rate of survival and decreases breast cancer reoccurrences by more than 50%.The groundbreaking work and generosity of event founder Lilly Tartikoff, the Entertainment IndustryFoundation, and REVLON CEO Ronald O. Perelman, along with the unprecedented fundraising efforts ofRun/Walk participants in New York and Los Angeles, have advanced the science of cancer research by 6to 8 years.2012 New York BeneficiariesLearn more about the 2012 EIF REVLON Run/Walk For Women Beneficiaries and how they make adifference by, visiting our website at revlonrunwalk.org under the “Who We Support” section.The Facts About Women’s Cancers:It is estimated that in 2012:More than 318,000 new cases of women’s cancers will be diagnosed this year in the U.S.Approximately 40,000 women will die from breast cancer in the United StatesApproximately 22,000 new cases of ovarian cancer are expected this yearAbout 15,500 women will die of ovarian cancerSource: American Cancer Society Facts & Figures 2011, National Cancer Institute Centers for Disease ControlEarly Detection is the Key - The American Cancer Society Recommends:All women conduct monthly breast self-examinationsAll women have an annual clinical examination by a health care professionalAll women aged 40 and over have a yearly mammogramHelp in the Fight Celebrate Triumphs Share Stories Make a Difference